: +31 (0) 317 453 908
: info@check-points.com

home image 1

New: Real-Time detection

Check-MDR Carba

Real-Time detection of carbapenemases: OXA-48, IMP, VIM, KPC, NDM

Check-MDR ESBL

Real-Time detection of ESBLs: CTX-M, TEM ESBL, SHV ESBL

Read more

Meet us at ECCMID

Learn more about our latest products

Visit our booth (#323) at the 22nd ECCMID in London 31 March-3 April.

Read more

Check-MDR CT103

Microarray identification of ESBL, carbapenemase and AmpC genes

- Confirm suspected multidrug resistance

- Improve your epidemiological insight

- Exclude outbreaks

Read more

Check&Trace Salmonella

Salmonella serotyping plays an essential role in any Salmonella reduction program.

To combat foodborne diseases and to reduce Salmonella contaminations considerably, Check&Trace Salmonella (previously Premi®Test Salmonella) allows you to detect and identify Salmonella Serotypes in one reliable routine test.

Read more

Company News

"It provided definitive results within the same working day, allowing rapid implementation of isolation measures and appropriate antibiotic treatment"

Naas et al.

Antimicrobial Agents and Chemotherapy, 2010

Check-Points, Life Sciences

Check-Points develops diagnostic products for specific applications for everyday use in clinics, institutes and companies based on our proprietary rapid microarray system. 

Antibiotic Resistance

Check-Points is the first to introduce rapid molecular assays with the highest sensitivity and specificity for Carbapenemases, AmpC and ESBL. Rapid and accurate confirmation of antibiotic resistance is crucial for optimal patient treatment and infection control.

Check&Trace Salmonella

Premi® Test Salmonella allows for fast and reliable routine molecular serotyping of Salmonella in both reference institutes and food companies. Serotyping of Salmonella has proven to be essential in any Salmonella reduction program.


newsletter

Thank you for your interest!

The Check-Points newsletter helps you to stay updated on the the latest developments in gram negative antibiotic resistance.

Sent on a quarterly basis, the newsletter features the latest news from Check-Points as well as summaries of key publications in the field and links to relevant news stories. Special issues will appear for ICAAC and ECCMID.

Subscribe below: